These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 8353318)

  • 41. Pathophisiology of sickle cell disease and new drugs for the treatment.
    De Franceschi L
    Mediterr J Hematol Infect Dis; 2009 Dec; 1(1):e2009024. PubMed ID: 21415994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Systematic enhancement of polymerization of recombinant sickle hemoglobin mutants: implications for transgenic mouse model for sickle cell anemia.
    Li X; Mirza UA; Chait BT; Manning JM
    Blood; 1997 Dec; 90(11):4620-7. PubMed ID: 9373274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Physiologic decline in fetal hemoglobin parameters in infants with sickle cell disease: implications for pharmacological intervention.
    Marcus SJ; Ware RE
    J Pediatr Hematol Oncol; 1999; 21(5):407-11. PubMed ID: 10524455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sickle cell disease: progress towards combination drug therapy.
    Pace BS; Starlard-Davenport A; Kutlar A
    Br J Haematol; 2021 Jul; 194(2):240-251. PubMed ID: 33471938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
    Connes P; Machado R; Hue O; Reid H
    Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythrocyte-active agents and treatment of sickle cell disease.
    Brugnara C; De Franceschi L; Beuzard Y
    Semin Hematol; 2001 Oct; 38(4):324-32. PubMed ID: 11605167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mesoscopic Adaptive Resolution Scheme toward Understanding of Interactions between Sickle Cell Fibers.
    Lu L; Li H; Bian X; Li X; Karniadakis GE
    Biophys J; 2017 Jul; 113(1):48-59. PubMed ID: 28700924
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.
    Evans E; Mohandas N; Leung A
    J Clin Invest; 1984 Feb; 73(2):477-88. PubMed ID: 6699172
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathophysiology of sickle cell disease].
    Elion J; Laurance S; Lapouméroulie C
    Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
    Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
    Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease.
    Eaton WA
    Mol Aspects Med; 2022 Apr; 84():100971. PubMed ID: 34274158
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacological modification of oxygen affinity improves deformability of deoxygenated sickle erythrocytes: a possible therapeutic approach to sickle cell disease.
    Keidan AJ; Sowter MC; Johnson CS; Marwah SS; Stuart J
    Clin Sci (Lond); 1989 Apr; 76(4):357-62. PubMed ID: 2714049
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes.
    Spector J; Kodippili GC; Ritchie K; Low PS
    PLoS One; 2016; 11(9):e0162514. PubMed ID: 27598991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymerization and sickle cell disease: a molecular view.
    Ferrone FA
    Microcirculation; 2004 Mar; 11(2):115-28. PubMed ID: 15280087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Concurrent sickle cell anemia and alpha-thalassemia. Effect on pathological properties of sickle erythrocytes.
    Embury SH; Clark MR; Monroy G; Mohandas N
    J Clin Invest; 1984 Jan; 73(1):116-23. PubMed ID: 6690472
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Polymerization of sickle cell hemoglobin at arterial oxygen saturation impairs erythrocyte deformability.
    Green MA; Noguchi CT; Keidan AJ; Marwah SS; Stuart J
    J Clin Invest; 1988 Jun; 81(6):1669-74. PubMed ID: 3384944
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse.
    Kaul DK; Fabry ME; Costantini F; Rubin EM; Nagel RL
    J Clin Invest; 1995 Dec; 96(6):2845-53. PubMed ID: 8675655
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Rheology of sickle cells and its role in microcirculatory dynamics.
    Chien S; Kaperonis AA; King RG; Lipowsky HH; Schmalzer EA; Sung LA; Sung KL; Usami S
    Prog Clin Biol Res; 1987; 240():151-65. PubMed ID: 3615484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sickle cell rheology is determined by polymer fraction--not cell morphology.
    Hiruma H; Noguchi CT; Uyesaka N; Hasegawa S; Blanchette-Mackie EJ; Schechter AN; Rodgers GP
    Am J Hematol; 1995 Jan; 48(1):19-28. PubMed ID: 7832188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sickle cell vasoocclusion: many issues and some answers.
    Kaul DK; Nagel RL
    Experientia; 1993 Jan; 49(1):5-15. PubMed ID: 8428611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.